Who
Stanley Lapidus
Director
Company insider
Files Form 4 as: Director, Lucid Diagnostics; Director, T2 Biosystems.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $211K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 17 Jun 2016
- Last trade
- 20 Feb 2026
- Last filed
- 24 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —123,000 at $0.00 | filing |
| 20 Feb 2026filed 24 Feb 2026 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —123,000 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Code A | —112,800 at $0.00 | filing |
| 22 Feb 2024filed 23 Feb 2024 | LUCD Lucid Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 26 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $15K10,000 at $1.47 | filing |
| 26 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K10,000 at $1.43 | filing |
| 26 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $14K9,747 at $1.45 | filing |
| 25 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $286200 at $1.43 | filing |
| 21 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $144100 at $1.44 | filing |
| 21 Sep 2023filed 22 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $144100 at $1.44 | filing |
| 20 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,9373,405 at $1.45 | filing |
| 20 Sep 2023filed 27 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $593412 at $1.44 | filing |
| 20 Sep 2023filed 22 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $4,9373,405 at $1.45 | filing |
| 20 Sep 2023filed 22 Sep 2023 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $593412 at $1.44 | filing |
| 31 Jan 2023filed 2 Feb 2023 | LUCD Lucid Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 20 Sep 2022filed 22 Sep 2022 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $29K17,000 at $1.71 | filing |
| 20 Sep 2022filed 22 Sep 2022 | LUCD Lucid DiagnosticsDiagnostics & Labs | SEC FORM 4 Sold | $29K16,864 at $1.70 | filing |
| 18 Feb 2022filed 23 Feb 2022 | LUCD Lucid Diagnosticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —59,000 at $0.00 | filing |
| 11 Jun 2019filed 13 Jun 2019 | T2 Biosystems | SEC FORM 4 Sold | $13K9,000 at $1.44 | filing |
| 8 Jun 2019filed 11 Jun 2019 | T2 Biosystemsoption or derivative | SEC FORM 4 Code M | —9,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.